Quick Answer
Equillium, Inc. reported Operating Income Loss of -$23.63 million for the year ending 2025.
- Equillium, Inc. showed a decrease of -185.8% in Operating Income Loss from 2024 to 2025.
- This data is from Equillium, Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: -$83.7 thousand | Q1 2018: -$1.04 million | Q2 2018: -$1.13 million | Q3 2018: -$2.23 million | Q1 2019: -$6.35 million | Q2 2019: -$6.44 million | Q3 2019: -$6.32 million | Q1 2020: -$7.45 million | Q2 2020: -$6.61 million | Q3 2020: -$6.52 million | Q1 2021: -$8.70 million | Q2 2021: -$8.84 million | Q3 2021: -$9.86 million | Q1 2022: -$37.33 million | Q2 2022: -$13.55 million | Q3 2022: -$13.24 million | Q1 2023: -$4.11 million | Q2 2023: -$3.59 million | Q3 2023: -$3.62 million | Q1 2024: -$2.79 million | Q2 2024: -$100.0 thousand | Q3 2024: -$679.0 thousand | Q1 2025: -$8.87 million | Q2 2025: -$6.23 million | Q3 2025: -$4.58 million.
- Over the full 8 years of available data (2018 to 2025), Equillium, Inc.'s Operating Income Loss has declined by 174.3%.
- Historical annual values: Fiscal year 2025: -$23.63 million | Fiscal year 2024: -$8.27 million | Fiscal year 2023: -$14.52 million | Fiscal year 2022: -$62.08 million | Fiscal year 2021: -$37.79 million | Fiscal year 2020: -$29.55 million | Fiscal year 2019: -$26.73 million | Fiscal year 2018: -$8.62 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: